Media
Drug Access Gaps Persist in Low-Income Countries Despite Pharmaceutical Progress, Says New Report
11 November 2026
Date
11 November 2026
NXTin Health covers the 2026 Access to Medicine Index
An article for NXTin Health covers the launch of the 2026 Access to Medicine Index, highlighting the report's key findings, company ranking and spotlight on diabetes.
The article covers the report's three key findings on access planning, oncology and inclusive business models, and additionally, touches on the changes to the company ranking since the previous iteration of the report.Â
Jayasree K. Iyer, CEO of the Access to Medicine Foundation, is quoted: "This 10th edition of the Access to Medicine Index is a milestone. Over two decades, we have uniquely tracked how the world’s leading pharmaceutical companies have made essential health products more available, affordable and accessible in low- and middle-income countries (LMICs).Â